Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?

Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951.

Abstract

The SARS-CoV-2 virus causes various conditions, from asymptomatic infection to the fatal coronavirus disease 2019 (COVID-19). An intact immune system can overcome SARS-CoV-2 and other viral infections. Defective natural, mainly interferon I- and III-dependent, responses may lead to the spread of the virus to multiple organs. Adaptive B- and T-cell responses, including memory, highly influence the severity and outcome of COVID-19. With respect to B-cell immunity, germinal centre formation is delayed or even absent in the most severe cases. Extrafollicular low-affinity anti-SARS-CoV-2 antibody production will occur instead of specific, high-affinity antibodies. Helper and CD8+ cytotoxic T-cells become hyperactivated and then exhausted, leading to ineffective viral clearance from the body. The dysregulation of neutrophils and monocytes/macrophages, as well as lymphocyte hyperreactivity, might lead to the robust production of inflammatory mediators, also known as cytokine storm. Eventually, the disruption of this complex network of immune cells and mediators leads to severe, sometimes fatal COVID-19 or another viral disease.

Keywords: B- and T-cell memory; COVID-19; SARS-CoV-2; adaptive immunity; antibodies; cytokine storm; cytokines; viral infection.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Virus Diseases*

Substances

  • Antibodies, Viral

Grants and funding

This research was supported by the European Union and the State of Hungary and co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/2-11/1-2012-0001 ‘National Excellence Program’ (Z.S.) and by the European Union grant GINOP-2.3.2-15-2016-00050 (Z.S.).